# A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

> **NCT06141577** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 8 (actual)

## Conditions studied

- GERD

## Interventions

- **DRUG:** UI059
- **DRUG:** UIC202201

## Key facts

- **NCT ID:** NCT06141577
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-08
- **Primary completion:** 2023-11-07
- **Final completion:** 2023-11-15
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141577, "A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06141577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*